SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
UGI Corporation (UGIC) trades at a trailing P/E of 18.7. Trailing earnings yield is 5.35%. PEG 0.13 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (75/100, Pass) — P/E is below market average (18.7); PEG ≤ 1.0 — Peter Lynch undervalued (0.13); earnings yield beats bond yields (5.35%).
- PEG Ratio 0.13 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 5.35% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 46/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
75/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — UGIC
Valuation Multiples
P/E (TTM)18.7
Forward P/EN/A
PEG Ratio0.13
Forward PEGN/A
P/B Ratio0.00
P/S Ratio1.74
EV/EBITDA0.0
Per Share Data
EPS (TTM)$3.09
Book Value / Share$0.00
Revenue / Share$33.25
FCF / Share$0.00
Yields & Fair Value
Earnings Yield5.35%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$2.08 |
$5.69B |
$364.7M |
6.4% |
| 2017 |
$2.46 |
$6.12B |
$436.6M |
7.1% |
| 2018 |
$4.06 |
$7.65B |
$719M |
9.4% |
| 2019 |
$1.41 |
$7.32B |
$256M |
3.5% |
| 2020 |
$2.53 |
$6.56B |
$532M |
8.1% |
| 2021 |
$6.92 |
$7.45B |
$1.47B |
19.7% |
| 2022 |
$4.97 |
$10.11B |
$1.07B |
10.6% |
| 2023 |
$-7.16 |
$8.93B |
$-1.5B |
-16.8% |
| 2024 |
$1.25 |
$7.21B |
$269M |
3.7% |
| 2025 |
$3.09 |
$7.29B |
$678M |
9.3% |
